Price: $6.33
· 1 day: +12.43% · 5 days: -4.09% · 1 month: -16.93% · YTD: -38.30%
As of 2026-11-06 21:00 UTC.
52-week range: $5.39 – $14.45 (currently at 10% of the range).
QUBT is in a downtrend, momentum soft. $7 is the level overhead; $6 the first support below.
5 of 6 technical checks lean bearish.
| Trend | Downtrend · below 50-day & below 200-day |
|---|---|
| Momentum | RSI 48.71 · neutral · MACD bearish |
| Trend strength | ADX 33.9 · strong trend |
| Location | -16.2% vs 50-day MA |
| 52-week range | -53% from high · +12% from low |
| Volatility | ATR 0.43 · ~6.8%/day |
| Level | Type | Distance |
|---|---|---|
| $7.0 (resistance) | round | 10.58% |
| $7.3 (resistance) | swing zone | 15.32% |
| $7.55 (resistance) | sma 50 | 19.27% |
| $6.0 (support) | round | -5.21% |
| $5.63 (support) | 52w low | -11.06% |
| $5.0 (support) | round | -21.01% |
| RSI (14) | 48.71 | MACD | -0.3957 |
|---|---|---|---|
| ADX (14) | 33.9 | ATR (14) | 0.43 |
| 50-day average | $7.55 | 200-day average | $8.59 |
Next earnings: 2026-11-09. QUBT earnings date, time and past reactions.
Report of 2026-11-05.
Quantum Computing Inc. (QUBT) fell 7.3% on November 5, 2026, to $5.96, a new 52-week low, as the stock continues to bleed in a clear downtrend. The weekly trend is down, price is below its 40-week average, and the stock has lagged the S&P 500 by 21% over the last 50 days. With a high-conviction bearish stance, the evidence points to further downside, with a daily close below $5.0 opening the door to $4.0. The picture only changes on a weekly close above $7.61.
QUBT's slide is not a one-day event. The stock has dropped 27.1% from its October 2, 2026 peak of $8.18, and the 5-day loss of 12.6% is far worse than the sector's 9.7% decline or the market's 1.1% dip. The stock's own weakness accounts for most of the move: it underperformed XLK by 2.9% in the last five days. There is no single piece of news driving the selloff; the most recent headlines, like the October 15, 2026 PR Newswire piece on post-quantum security, are about the sector, not QUBT specifically. The market is pricing in a company that has yet to prove it can turn its technology into revenue, and the stock is being sold on that reality.
What was already priced in? The stock's 1-month decline of 24.2% and 6-month drop of 37.7% show that investors have been de-risking for weeks. The 50-day average at $7.61 has acted as resistance, and the stock has not closed above it since early October. The 200-day average at $8.62 is even higher, confirming the long-term downtrend. The recent peak on October 2, 2026, was a dead-cat bounce; since then, every rally has been sold.
The sector backdrop is not helping. XLK is down 15.6% over the last month, and the broader market is off 2.3%. But QUBT's underperformance is not just sector beta. The stock is down 21% relative to SPY over 50 days and 13% relative to XLK. That is stock-specific weakness, not a market or sector issue. The debate among investors is whether QUBT's quantum computing technology is worth the wait. Bulls point to partnerships like the one with INmune Bio to apply quantum optimization to Alzheimer's research, and the broader sector momentum from deals like IonQ's $1.3 billion acquisition of a cybersecurity firm. Bears argue that QUBT is a small-cap with a market cap of $1.35 billion, no consensus analyst rating, and a mean price target of $18.67 that is 68% above the current price—a target that seems disconnected from the stock's trajectory. The stock is down 58% from its 52-week high of $14.19, and the 52-week low is today's price, which is not a sign of accumulation.
The long-term thesis is broken. The stock is below its 40-week average, and the weekly trend is down. The 50-day average at $7.61 is below the 200-day average at $8.62, a bearish alignment. The stock is in a clear downtrend, and there is no sign of a bottom. The 14-day RSI at 42 is not oversold, so there is room for more downside. Volume is 80% below its 20-day average, which means the selling is not climactic; it is a slow bleed.
For the next 2–6 weeks, the balance of evidence is negative. The daily trend runs with the weekly downtrend, and the stock is lagging both the market and its sector. The conviction is high, with 3 of 4 points supporting a bearish stance. The strongest case against this reading is the historical pattern: after a one-day drop of more than 5%, the stock has been higher a month later 70.9% of the time, with a median gain of 5.4%. That suggests a possible bounce, but it is not enough to change the trend. The stock is still below its 50-day average, and any bounce is likely to be sold. The math does not support a long position from here.
The structure holds below $6.0, a round number where sellers have shown up on rallies. The stock closed at $5.96, just below that level, and the next support is $5.0, a round number. A daily close below $5.0 would be a downside breakout, with a stop at $6.09 (the round $6.0 plus a quarter of ATR). The target is $4.0, a round number, which gives a reward-to-risk of 0.9 to 1. That does not meet the 3-to-1 threshold that makes a trade worth the risk. To get to 3-to-1, the target would need to be around $3.0, which is not in the current support levels.
The trend would end on a weekly close above $7.61, the 50-day average. That is the level where the downtrend would be broken. Until then, the path of least resistance is down. The 52-week low is today's price, and the stock is at its lowest point in a year. The next earnings report is November 9, 2026, and that could be a catalyst for a move, but the trend is down.
The picture changes on a weekly close above $7.61, the 50-day average. That would be the first sign that buyers are stepping in. The one non-price fact that would change the picture is a surprise in earnings on November 9, 2026, such as a revenue beat or a clear path to profitability. Without that, the downtrend is likely to continue.
Interactive QUBT chart and analyst chat · Market terminal — movers, signals and news · Use MarketCrew inside Claude · Use MarketCrew inside ChatGPT · Top gainers today · 52-week highs